:internalReference - erlotinib-hydrochloride | 183319-69-9
Erlotinib Hydrochloride
CAS :Formule :C22H23N3O4·HClDegré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :429.90Erlotinib Hydrochloride
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C22H23N3O4·HClCouleur et forme :Pale Yellow PowderMasse moléculaire :429.14553Erlotinib hydrochloride
CAS :Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.Formule :C22H23N3O4·HClDegré de pureté :99.78% - 99.85%Couleur et forme :White Or Off-White PowderMasse moléculaire :429.9Erlotinib hydrochloride
CAS :Erlotinib hydrochlorideDegré de pureté :≥98%Masse moléculaire :429.9g/molErlotinib hydrochloride
CAS :Formule :C22H23N3O4·HClDegré de pureté :≥ 98.0% (dried basis)Couleur et forme :White to off-white powderMasse moléculaire :429.90Erlotinib hydrochloride
CAS :Formule :C22H24ClN3O4Degré de pureté :98%Couleur et forme :Solid, Crystalline PowderMasse moléculaire :429.9Erlotinib Hydrochloride
CAS :Produit contrôléFormule :C22H23N3O4·ClHCouleur et forme :White To Light YellowMasse moléculaire :429.90Erlotinib Hydrochloride Salt
CAS :Erlotinib Hydrochloride SaltFormule :C22H23N3O4·ClHDegré de pureté :By hplc: 99.9% by area (Typical Value in Batch COA)Couleur et forme : white to off-white crystalline solidMasse moléculaire :429.90g/molErlotinib Hydrochloride (Tarceva)
CAS :Produit contrôléApplications Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic.
References Moyer, J.D., et al.: Cancer Res., 57, 4838 (1997), Hidalgo, M., et al.: J. Clin. Oncol., 19, 3267 (2001), Perez-Soler, R., et al.: J. Clin. Oncol., 22, 3238 (2004), Blackhall, F.H., et al.: Expert Opin. Pharmacother., 6, 995 (2005),Formule :C22H23N3O4·ClHCouleur et forme :White To Light YellowMasse moléculaire :429.90Erlotinib hydrochloride - Bio-X ™
CAS :Erlotinib is a drug that is used to treat human malignancies. It is a type of kinase inhibitor that inhibits the EGFR tyrosine kinase, preventing the activation of downstream signalling pathways. Erlotinib has been shown to be effective in treating squamous cell carcinoma, melanoma, and other types of skin cancer. Additionally, Erlotinib has potential for use as an anti-inflammatory agent in the treatment of psoriasis and ulcerative colitis.
Formule :C22H23N3O4·HClDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :429.9 g/mol
